For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
What Trump’s vaccine executive order actually does
Yesterday, President Trump signed an executive order directing federal health agencies to revise childhood vaccine recommendations, reducing the number of vaccines recommended for…
Blog
Trump administration decision highlights disastrous Part D redesign
The Trump administration recently announced the end of a demonstration project that was pulled together by the Biden administration as the Inflation Reduction…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
Newsletter
Stem Cells, Regulating Lawn Mowers and Standing up to the SEC
The National Academy of Sciences argues for continued use of embryonic stem cells. The Environmental Protection Agency requires that new gas-powered lawn mowers come with…
Newsletter
Economic Projections, Comcast Sues the FCC and Cholesterol Drugs
A new report from the Federal Reserve projects continued slow growth and a weak business climate. Comcast sues the Federal Communications Commission over…
Newsletter
Stem Cells, Mad Cow Disease and Cuba’s Police
Scientists hail a new breakthrough in stem cell research. A federal Appeals Court rules that the U.S. Department of Agriculture can forbid private meat packers…
Op-Eds
Cholesterol Drug Scare Shenanigans
Why is the editor of the New England Journal of Medicine encouraging a cancer scare over the cholesterol-lowering drug Vytorin? Is he overcompensating for past…
News Release
Public Funding for Stem Cell Research: Boon or Boondoggle?
Debates over the ethics of research using human embryonic stem cells continue long after the Bush Administration’s ban on federal tax-funding for such research. But,…
Study
Public Stem Cell Research Funding
The best way to make progress in stem cell research is to allow the private sector to grow, unimpeded by regulation and controversy.